Company profile

Suzhou Zelgen Biopharmaceuticals

688266 · SSE STAR Market

Public Market Listing

688266SSE STAR Market

SSE STAR Market primary exchange listing

Live quotes, historical charts, and market capitalization for Suzhou Zelgen Biopharmaceuticals are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(2 total)
2Total Assets
0Approved
1Phase 3 / Filed
1Phase 1–2 / Early
2Diseases
Quick filter:
Showing 2 of 2 assets
Target & Modality
jaktinib
Phase 3
JAK1/2/3Small molecule
Atopic Dermatitis
ZG005
Phase 2
PD-1 and TIGITBiologic — subtype unspecified
Non-Small Cell Lung Cancer

Upcoming events

Research

Unlock the company readout calendar

Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.

Financial reports

Research

Unlock sourced financial history

Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.

Educational data tool. Figures are sourced from company filings and press releases: see each row's filing link. Share price is delayed (~15min) and refreshed periodically, not a real-time feed.